2m 2m 2m 2m 2m 2m 2m
TARSUS PHARMA (TARS)
NASDAQ
$72.26+$0.18 (+0.25%)
Price as of Oct 22, 2026 7:30 PM EDT- $3.3BMarket Cap
- 5.50%1-Year Change
- BiotechnologyIndustry
TARSUS PHARMA (TARS)
$72.26+$0.18 (+0.25%)
TARS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $72.08 | ||
Change | -$0.53 (-0.75%) | ||
Open | $70.93 | ||
High | $73.11 | ||
Low | $69.55 | ||
Previous Close | $70.50 | ||
Volume | 688,656 | ||
30-Day Average Volume | 1,010,595 | ||
1-Week Change | -2.48% | ||
1-Month Change | -8.99% | ||
1-Year Change | 2.62% | ||
3-Year Change | 437.76% | ||
5-Year Change | 156.08% | ||
Fundamentals | |||
Shares Outstanding | 46.8M | ||
Total Assets | $611.1M | ||
Market Cap | $3.3B | ||
Enterprise Value | $3.2B | ||
Period: QTR TTM FY | |||
Revenue | $173.9M | ||
Net Income | -$18.6M | ||
Free Cash Flow | $57.2M | ||
EBIT | -$13.7M | ||
EBITDA | -$13.4M | ||
Net Working Capital | $386.2M | ||
EPS | -$0.43 | ||
Enterprise Value/EBITDA | -236 | ||
Enterprise Value/Revenue | 18 | ||
P/B | 10 | ||
P/E | -164 | ||
PEG | 1 | ||
Price/Free Cash Flow | 58 | ||
Price/Operating Cash Flow | 54 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue